Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 30.81 USD 0.23% Market Closed
Market Cap: 2B USD
Have any thoughts about
Tandem Diabetes Care Inc?
Write Note

Wall Street
Price Targets

TNDM Price Targets Summary
Tandem Diabetes Care Inc

Wall Street analysts forecast TNDM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNDM is 54.42 USD with a low forecast of 18.18 USD and a high forecast of 78.75 USD.

Lowest
Price Target
18.18 USD
41% Downside
Average
Price Target
54.42 USD
77% Upside
Highest
Price Target
78.75 USD
156% Upside

TNDM Last Price Targets
Tandem Diabetes Care Inc

The latest public price target was made on Nov 7, 2024 by Jeff Johnson from Robert W. Baird , who expects TNDM stock to rise by 20% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jeff Johnson
Robert W. Baird
37 USD
Upside 20%
2 weeks ago
Nov 7, 2024
Tandem Diabetes Care (TNDM) PT Lowered to $37 at Baird
StreetInsider
Lee Hambright
Bernstein
42 USD
Upside 36%
2 weeks ago
Nov 5, 2024
Bernstein SocGen Group Starts Tandem Diabetes Care (TNDM) at Outperform
StreetInsider
David Roman
Goldman Sachs
46 USD
Upside 49%
1 month ago
Oct 4, 2024
This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Benzinga
Shagun Singh
RBC Capital
65 USD
Upside 111%
1 month ago
Oct 2, 2024
Tandem Diabetes initiated with an Outperform at RBC Capital
TheFly
William Plovanic
Canaccord Genuity
57 USD
Upside 85%
3 months ago
Aug 8, 2024
Tandem Diabetes initiated with a Buy at Canaccord
TheFly
Matt Miksic
Barclays
58 USD
Upside 88%
3 months ago
Aug 5, 2024
Tandem Diabetes price target raised to $58 from $55 at Barclays
TheFly
Matt O'Brien
Piper Sandler
55 USD
Upside 79%
3 months ago
Aug 2, 2024
Tandem Diabetes price target raised to $55 from $50 at Piper Sandler
TheFly
Jeff Johnson
Robert W. Baird
39 USD
Upside 27%
3 months ago
Aug 2, 2024
Tandem Diabetes price target raised to $39 from $36 at Baird
TheFly
Steven Lichtman
Oppenheimer
58 USD
Upside 88%
5 months ago
Jun 10, 2024
Tandem Diabetes Care (TNDM) PT Raised to $58 at Oppenheimer
StreetInsider
Matthew Blackman
Stifel Nicolaus
60 USD
Upside 95%
5 months ago
May 29, 2024
Tandem Diabetes Care (TNDM) PT Raised to $60 at Stifel
StreetInsider
Brooks O'Neil
Lake Street
75 USD
Upside 143%
6 months ago
May 22, 2024
Tandem Diabetes price target raised to $75 from $60 at Lake Street
TheFly
Jeff Johnson
Robert W. Baird
36 USD
Upside 17%
6 months ago
May 3, 2024
Tandem Diabetes price target raised to $36 from $28 at Baird
TheFly
Matt O'Brien
Piper Sandler
50 USD
Upside 62%
6 months ago
May 3, 2024
Tandem Diabetes price target raised to $50 from $35 at Piper Sandler
TheFly
Lawrence Biegelsen
Wells Fargo
45 USD
Upside 46%
6 months ago
Apr 29, 2024
Wells Fargo Upgrades Tandem Diabetes Care (TNDM) to Overweight, 'We See Positive Risk/Reward at Current Valuation'
StreetInsider
Danielle AntalffyMike Kratky
Leerink Partners
45 USD
Upside 46%
6 months ago
Apr 25, 2024
Leerink Partners Upgrades Tandem Diabetes Care (TNDM) to Outperform
StreetInsider
Matthew Blackman
Stifel Nicolaus
40 USD
Upside 30%
7 months ago
Apr 22, 2024
Tandem Diabetes Care (TNDM) PT Raised to $40 at Stifel
StreetInsider
Kenneth Leon
CFRA
36 USD
Upside 17%
7 months ago
Apr 11, 2024
Tandem Diabetes Care (TNDM) PT Raised to $36 at CFRA
StreetInsider
Mathew Blackman
Stifel Nicolaus
37 USD
Upside 20%
7 months ago
Mar 25, 2024
Tandem Diabetes upgraded to Buy at Stifel on strong Mobi adoption
TheFly
Show More Price Targets
Show Less Price Targets
Jeff Johnson
Robert W. Baird
Price Target 37 USD
Upside/Downside 20%
View Source
Lee Hambright
Bernstein
Price Target 42 USD
Upside/Downside 36%
View Source
David Roman
Goldman Sachs
Price Target 46 USD
Upside/Downside 49%
View Source
Shagun Singh
RBC Capital
Price Target 65 USD
Upside/Downside 111%
View Source
William Plovanic
Canaccord Genuity
Price Target 57 USD
Upside/Downside 85%
View Source
Matt Miksic
Barclays
Price Target 58 USD
Upside/Downside 88%
View Source
Matt O'Brien
Piper Sandler
Price Target 55 USD
Upside/Downside 79%
View Source
Jeff Johnson
Robert W. Baird
Price Target 39 USD
Upside/Downside 27%
View Source
Steven Lichtman
Oppenheimer
Price Target 58 USD
Upside/Downside 88%
View Source
Matthew Blackman
Stifel Nicolaus
Price Target 60 USD
Upside/Downside 95%
View Source
Brooks O'Neil
Lake Street
Price Target 75 USD
Upside/Downside 143%
View Source
Jeff Johnson
Robert W. Baird
Price Target 36 USD
Upside/Downside 17%
View Source
Matt O'Brien
Piper Sandler
Price Target 50 USD
Upside/Downside 62%
View Source
Lawrence Biegelsen
Wells Fargo
Price Target 45 USD
Upside/Downside 46%
View Source
Danielle AntalffyMike Kratky
Leerink Partners
Price Target 45 USD
Upside/Downside 46%
View Source
Matthew Blackman
Stifel Nicolaus
Price Target 40 USD
Upside/Downside 30%
View Source
Kenneth Leon
CFRA
Price Target 36 USD
Upside/Downside 17%
View Source
Mathew Blackman
Stifel Nicolaus
Price Target 37 USD
Upside/Downside 20%
View Source
Show More Price Targets
Show Less Price Targets
Tandem Diabetes Care Inc Competitors:
Price Targets
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
38% Upside
4543
Terumo Corp
12% Upside
300298
Sinocare Inc
39% Upside
SYK
Stryker Corp
6% Upside
338220
Vuno Inc
95% Upside
LIVN
LivaNova PLC
40% Upside
MASI
Masimo Corp
0% Downside
INMD
Inmode Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Tandem Diabetes Care Inc

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 34%. The projected CAGR for the next 3 years is 15%.

34%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Tandem Diabetes Care Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNDM's stock price target?
Price Target
54.42 USD

According to Wall Street analysts, the average 1-year price target for TNDM is 54.42 USD with a low forecast of 18.18 USD and a high forecast of 78.75 USD.

What is Tandem Diabetes Care Inc's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Tandem Diabetes Care Inc's revenue is 34%. The projected CAGR for the next 3 years is 15%.

Back to Top